A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas

Eur J Cancer. 1992;28A(8-9):1590. doi: 10.1016/0959-8049(92)90563-h.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Aged
  • Drug Evaluation
  • Epirubicin / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*

Substances

  • Epirubicin